Pacific Biosciences Of California (PACB) Net Income (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Net Income of -$8.3 million for Q1 2026, up 98.06% year-over-year from -$4.2 million in Q1 2025, and up 79.5% quarter-over-quarter from -$40.4 million in Q4 2025.
Pacific Biosciences Of California (PACB) Net Income (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Net Income history runs 17 years deep, the most recent figure standing at -$8.3 million for Q1 2026.
- In Q1 2026, Net Income rose 98.06% year-over-year to -$8.3 million; the TTM figure through Mar 2026 stood at -$128.6 million (up 80.45% YoY), while the FY2025 annual figure was -$546.4 million, down 76.34% from the prior year.
- Net Income for Q1 2026 stood at -$8.3 million, up from -$40.4 million in the prior quarter.
- The five-year high for Net Income was $2.4 million in Q4 2024, with the low at -$426.1 million in Q1 2025.
- The 5-year median for Net Income is -$71.4 million (2022), against an average of -$87.4 million.
- The sharpest annual moves came in 2024 and 2025: Net Income soared 102.89% in 2024, then slumped 1802.7% in 2025.
- Pacific Biosciences Of California's Net Income stood at -$84.4 million in 2022, then gained by 2.8% to -$82.0 million in 2023, then jumped by 102.89% to $2.4 million in 2024, then plunged by 1802.7% to -$40.4 million in 2025, then jumped by 79.5% to -$8.3 million in 2026.
- Business Quant data shows PACB's Net Income at -$8.3 million in Q1 2026, -$40.4 million in Q4 2025, and -$38.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 618.38 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Pacific Biosciences Of California | 394.84 Mn | 157.97 Mn | 12.64 Mn | -44.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -44.74 Mn |
| Mar 31, 2026 | -8.28 Mn |
| Dec 31, 2025 | -40.37 Mn |
| Sep 30, 2025 | -38.00 Mn |
| Jun 30, 2025 | -41.93 Mn |
| Mar 31, 2025 | -426.08 Mn |
| Dec 31, 2024 | 2.37 Mn |
| Sep 30, 2024 | -60.73 Mn |
| Jun 30, 2024 | -173.32 Mn |
| Mar 31, 2024 | -78.18 Mn |
| Dec 31, 2023 | -82.02 Mn |
| Sep 30, 2023 | -66.87 Mn |
| Jun 30, 2023 | -69.83 Mn |
| Mar 31, 2023 | -88.02 Mn |
| Dec 31, 2022 | -84.38 Mn |
| Sep 30, 2022 | -76.97 Mn |
| Jun 30, 2022 | -71.39 Mn |
| Mar 31, 2022 | -81.50 Mn |
| Dec 31, 2021 | -69.33 Mn |
| Jun 30, 2021 | -88.19 Mn |